While prevention of kidney injury is highly dependent on early detection of potential risk, the industry has no solutions to address this need. Conventional products and protocols can only report kidney damage after it exists - not prevent it. The growing unmet need for early detection and prevention of risk and for the tools to improve themanagement of AKI patients in critical care have established the necessity of realtime renal diagnostics solutions. RenalSense's unique products will set new clinical gold standards, improve outcomes and reduce the cost of care.

Biotechnology

Health Diagnostics

RenalSense

Avi Kleiman

Giora Fishman

Michael Boxman

Yosh Mantinband

Yohanan Engelhardt

Moti Barda

Joseph Kochba

Mor Grinstein

Adam Goldberger

Leadership Team

Clinical Development Team

Product and Commercialization Team

��

Teams at RenalSense

Leadership Team

Clinical Development Team

Product and Commercialization Team

��������

Teams at RenalSense

Leadership Team

Clinical Development Team

Product and Commercialization Team

��